| Financial Year |
March 31 2023 |
| Monetary Funds |
141,241,629.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
621,699.02 |
| Accounts Receivable |
444,227,022.99 |
| Advances to Suppliers |
19,454,665.93 |
| Other Receivables |
20,626,482.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
171,995,126.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,405,030.59 |
| Total Current Assets |
1,004,243,009.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
22,053,083.36 |
| Investment Properties |
-- |
| Fixed Assetes |
366,200,463.27 |
| Under-construction Projects |
6,689,518.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
83,956,348.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
93,365.22 |
| Deferred Income Tax Assets |
19,549,160.27 |
| Other Non-Current Assets |
635,519.30 |
| Sub-Total of Non-Current Assets |
503,879,691.13 |
| Total Assets |
1,508,122,700.20 |
| Short-Term Loans |
472,091,722.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
69,364,733.80 |
| Accounts Payable |
298,992,945.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,287,532.89 |
| Taxes Payable |
16,666,789.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,417,026.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,715,625.39 |
| Other Current Liabilities |
4,067,251.93 |
| Sub-Total of Current Liabilities |
951,787,372.26 |
| Long-term Loans |
120,179,666.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,066,550.93 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
165,627,646.51 |
| Total Liabilities |
1,117,415,018.77 |
| Paid-In Capital(Or Share Stock) |
207,560,000.00 |
| Capital Surplus |
206,445,397.70 |
| Surplus Reserve |
40,788,568.76 |
| LESS:Treasury Stock |
51,152,000.00 |
| Undistributed Profits |
-17,113,405.51 |
| Minority Stockholder's Interest |
4,540,176.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
386,167,504.76 |
| Owner's Equity（Stockholder's Equity） |
390,707,681.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,508,122,700.20 |
